21004 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Somatostatins
COMPOSITIONS AND METHODS FOR TREATING ACROMEGALY
#2POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY
#3METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#4IMPROVED ORAL PHARMACEUTICAL FORMULATIONS OF THERAPEUTIC PEPTIDES AND PROTEINS
#5SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS
#6ORAL DOSAGE FORMS
#7SUSTAINED-RELEASE MICROPARTICLES CONTAINING DRUG AND PAMOIC ACID
#8IDENTIFICATION AND USE OF SHP2 CONFORMATIONAL DISRUPTORS FOR CANCER TREATMENT
#9ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE
#10LIPID DEPOT FORMULATIONS
#11CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
#12DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE
#13NOVEL COMPOSITION
#14Octreotide Depot Formulation with Constantly High Exposure Levels
#15POLYMER-COATED NANOPARTICLES AND PREPARATION METHOD THEREFOR
#16ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#17METHOD FOR PREPARING MICROSPHERE WITH IMPROVED SUSPENSION PERFORMANCE, USING COACERVATION
#18HYDRODYNAMIC GENE DELIVERY
#19ORAL OCTREOTIDE FOR TREATMENT OF DISEASE
#20CONTROLLED RELEASE PEPTIDE FORMULATIONS
#21SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#22PEPTIDE SLOW-RELEASE FORMULATIONS
#23AROMATIC BORON-CONTAINING COMPOUNDS AND INSULIN ANALOGS
#24INTRANASAL FORMULATIONS AND DELIVERY OF SOMATOSTATIN MIMETICS AND USES THEREOF
#25METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#26Method of treating diseases
#27Method of treating diseases
#28DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE
#29METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#30METHODS AND THREAPEUTIC COMBINATIONS FOR TREATING IDIOPATHIC INTRACRANIAL HYPERTENSION AND CLUSTER HEADACHES
#31POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY
#32METHOD OF DELIVERING A SOMATOSTATIN COMPOUND INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#33METHOD OF TREATING DISEASES
#34Octreotide Depot Formulation with Constantly High Exposure Levels
#35METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#36ORAL OCTREOTIDE THERAPY IN COMBINATION WITH DIGOXIN OR LISINOPRIL
#37ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#38ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE
#39DRUG DELIVERY SYSTEMS
#40SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS
#41C-Peptide as a Therapy for Patients with Diabetes
#42METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#43METHODS OF REDUCING THE LIKELIHOOD OF CARCINOID HEART DISEASE IN PATIENTS WITH NEUROENDOCRINE TUMORS
#44Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer, infections and autoimmune disorders
#45SOMATOSTATIN RECEPTOR-BASED CANCER THERAPY
#46EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE
#47ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#48ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE
#49Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
#50METHOD OF TREATING PSMA-EXPRESSING CANCERS
#51STABLE PEPTIDE FORMULATIONS FOR ORAL USE
#52LIPID DEPOT FORMULATIONS
#53INHIBITION OF TMEM16A BY BENZBROMARONE OR NICLOSAMIDE FOR TREATING POLYCYSTIC KIDNEY DISEASE AND/OR POLYCYSTIC LIVER DISEASE
#54Method of treating diseases
#55TRANSDERMAL ABSORPTION-TYPE PATCH
#56LIQUID POLYMER COMPOSITIONS AND SYSTEMS FOR EXTENDED DELIVERY OF PEPTIDES AS ACTIVE PHARMACEUTICAL INGREDIENTS
#57ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#58SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#59SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#60Pharmaceutical compositions for delivery of peptide
#61Drug for preventing and/or treating polycystic kidney disease
#62Method of treating diseases
#63METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#64ORAL OCTREOTIDE THERAPY IN COMBINATION WITH DIGOXIN OR LISINOPRIL
#65Sustained-release lipid preformulation and pharmaceutical composition for sustained-release injection in form of lipid solution containing same
#66Octreotide Microsphere-Based Arterial Embolization for Treating Obesity
#67Methods for imaging and treatment of somatostatin-receptor positive tumors
#68COMBINATION THERAPY
#69LIPOPHILIC PEPTIDE PRODRUGS
#70SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#71Solid formulation
#72PHARMACEUTICAL COMPOSITIONS AND METHODS
#73STORAGE STABLE SOMATOSTATIN-DOPAMINE CHIMERIC COMPOUNDS AND SALT FORMS THEREOF
#74CONTROLLED RELEASE PEPTIDE FORMULATIONS
#75Methods of treating hepatic encephalopathy
#76PEPTIDE SLOW-RELEASE FORMULATIONS
#77ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE
#78COMBINATION THERAPY
#79Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly
#80Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
#81Octreotide Depot Formulation with Constantly High Exposure Levels
#82Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof
#83LIPID DEPOT FORMULATIONS
#84Drug Delivery Systems
#85Glucagon receptor antagonists
#86ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#87Method of treating diseases
#88Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
#89Sulfur (VI) fluoride compounds and methods for the preparation thereof
#90METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#91Method of treating diseases
#92METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#93MEMBRANE EMULSIFICATION DEVICE FOR MICROSPHERE CREATION
#94CONTROLLED-RELEASE FORMULATIONS
#95CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
#96LIPOPHILIC PEPTIDE PRODRUGS
#97Nanovectors and uses
#98THERAPEUTIC COMPOUND FORMULATIONS
#99Arylfluorosulfate compounds and methods
#100Method for preparing micro-particles by double emulsion technique
#101Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer
#102SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#103PEPTIDE COMPOSITIONS AND METHODS OF USE
#104Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer infections and autoimmune disorders
#105Pharmaceutical compositions for delivery of peptide
#106Methods of treating hepatic encephalopathy
#107Pharmaceutical compositions and methods
#108Drug Delivery Systems
#109CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
#110Tumor treatment methods using cells that localize to the tumor
#111Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
#112Drug for preventing and/or treating polycystic kidney disease
#113METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#114TREATMENT OF HORMONAL DISORDERS OF GROWTH
#115Methods for treating osteoarthritis by administering linked variants of growth hormone and somatostatin
#116Method of treating diseases
#117Octreotide depot formulation with constantly high exposure levels
#118Pharmaceutical compositions and methods
#119ANTICANCER THERAPY
#120PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS
#121ARYLFLUOROSULFATE COMPOUNDS AND METHODS
#122PREPARATION METHOD OF SUSTAINED-RELEASE MICROPARTICLES
#123TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
#124Drug for preventing and/or treating polycystic kidney disease
#125Oral octreotide administered in combination with other therapeutic agents
#126PEPTIDE SLOW-RELEASE FORMULATIONS
#127Sulfur(VI) fluoride compounds and methods for the preparation thereof
#128Solid formulation
#129LIPID DEPOT FORMULATIONS
#130Methods of treating hepatic encephalopathy
#131Conjugates of somatostatin analogues
#132Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
#133Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer
#134Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-co-glycolide Polymers
#135Drug Delivery Systems
#136BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOF
#137OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS
#138Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
#139Somatostatin receptor-based cancer therapy
#140WOUND HEALING
#141Polypeptide complex of titin-telethonin beta-pleated sheet structure as polypeptide drug carrier, method of using the polypeptide complex, and fusion protein complex thereof
#142SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#143Methods and compositions for decreasing gastric emptying
#144DIHYDROTESTOSTERONE AND DIHYDROTESTOSTERONE DERIVATIVES AND PROMOTERS IN THE TREATMENT OF CANCER
#145Anticancer therapy
#146Treatment of hormonal disorders of growth
#147Methods of treating hepatic encephalopathy
#148Preparation of peptide loaded PLGA microspheres with controlled release characteristics
#149Sulfur(VI) fluoride compounds and methods for the preparation thereof
#150DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE
#151Treating liver diseases
#152COSMETIC PRODUCT WITH LIPOSOMAL GROWTH FACTORS
#153Neuroendocrine Tumor Treatment
#154Antagonists for abdominal vasopressin V2 receptor and uses thereof
#155CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
#156Pharmaceutical compositions and methods
#157Neuropeptide analogs, compositions, and methods for treating pain
#158Short interfering RNA (siRNA) analogues
#159Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
#160Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
#161Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
#162Conjugates of somatostatin analogues
#163Methods and compositions for decreasing gastric emptying
#164Method of treating diseases
#165Use of somatostatin analogs in control of hypoglycemia
#166Method for delivery of somatostatin into a lumen of the intestinal tract
#167COMBINATION THERAPY
#168Treating liver diseases
#169Drug for preventing and/or treating polycystic kidney disease
#170PEPTIDE SLOW-RELEASE FORMULATIONS
#171Pharmaceutical lipid compositions
#172Somatostatin-dopamine chimeric analogs
#173Solvent/polymer solutions as suspension vehicles
#174Treating liver diseases
#175Anticancer therapy
#176Oral administration of tocilizumab treatment of autoimmune disease
#177Methods of treating hepatic encephalopathy
#178Somatostatin-dopamine chimeric analogs
#179Neuroendocrine Tumor Treatment
#180Drug for preventing and/or treating polycystic kidney disease
#181Somatostatin receptor agonist formulations
#182Intermittent dosing regimen for treating breast cancer
#183Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors
#184TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#185Methods for treating benign prostatic hypertrophy (BPH)
#186Induction of differential stress resistance and uses thereof
#187Microspheres for controlled- or sustained-release delivery of therapeutics
#188Short interfering RNA (siRNA) analogues
#189OCTREOTIDE INJECTION
#190LIPID DEPOT FORMULATIONS
#191Controlled release peptide formulations
#192Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
#193Multicomponent compositions and their uses
#194Methods of delivering stable topical drug compositions
#195Methods of delivering stable topical drug compositions
#196TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#197OCTREOTIDE INJECTION
#198Somatostatin receptor-based cancer therapy
#199METHODS FOR THERAPEUTIC TREATMENT OF BENIGN PROSTATIC HYPERTROPHY (BPH)
#200Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes
#201Topical ophthalmic peptide formulation
#202Proteolytically resistant hydrogen bond surrogate helices
#203Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#204Methods of treating hepatic encephalopathy
#205Extended-release composition comprising a somatostatin derivative in microparticles
#206Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
#207Methods for detecting progenitor cells and uses thereof
#208Solvent/polymer solutions as suspension vehicles
#209Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues
#210Reverse hexagonal mesophases (H) and uses thereof
#211Solvent/polymer solutions as suspension vehicles
#212Induction of differential stress resistance and uses thereof
#213Methods for treatment of headaches by administration of oxytocin
#214USE OF SOMATOSTATIN ANALOGS IN MENINGIOMA
#215Treating liver diseases
#216Rapid opioid detoxification
#217Lipid depot formulations
#218Solvent/polymer solutions as suspension vehicles
#219Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
#220MICROPARTICLES COMPRISING SOMATOSTATIN ANALOGUES
#221USE OF SOMATOSTATIN OR AN ANALOGUE THEREOF IN COMBINATION WITH EXTERNAL RADIATION THERAPY
#222Treatment of non-proliferative cystic disease of the breast
#223Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
#224Reversible gel-forming compositions for controlled delivery of bioactive substances
#225Emulsion Method For Preparing Low Residual Solvent Microparticles
#226Method For Removing Residual Organic Solvent From Microparticles
#227Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof
#228Methods for treatment of headaches by administration of oxytocin
#229MICROSPHERES FOR THE SUSTAINED RELEASE OF OCTREOTIDE WITH A LOW INITIAL BURST
#230USE OF SOMATOSTATIN ANALOGS IN CLUSTER HEADACHE
#231Sustained release of microcrystalline peptide suspensions
#232TREATMENT OF INSULIN RESISTANCE/METABOLIC SYNDROME TO ALLEVIATE THE RISKS OF DEMENTIA
#233Solvent/polymer solutions as suspension vehicles
#234Octreotide depot formulation with constantly high exposure levels
#235Therapy procedure for drug delivery for trigeminal pain
#236METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#237Octreotide implant having a release agent
#238Pharmaceutical compositions
#239Method of modulating the proliferation of medullary thyroid carcinoma cells
#240WOUND HEALING
#241Oxotetrahydrofuran-2-yl-benzimidazole derivative
#242Topical drug delivery using phosphatidylcholine
#243PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF SOMATOSTATIN OR AN ANALOGUE THEREOF
#244Use of somatostatin analogs in control of hypoglycemia
#245Method Of Delivering Stable Topical Drug Compositions
#246Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#247PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN-DOPAMINE CONJUGATES
#248Methods for Therapeutic Treatment of Benign Prostatic Hypertrophy (BPH)
#249CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
#250USE OF SOMATOSTATIN OR ONE OF ITS ANALOGUES FOR PREPARING A MEDICAMENT INTENDED TO REGULATE THE OVARIAN FOLLICULAR RESERVE IN NON-MENOPAUSAL WOMEN
#251SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#252Controlled release formulations of octreotide
#253SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#254Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease
#255TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE
#256USE OF SOMATOSTATIN ANALOGS IN MENINGIOMA
#257Microparticles comprising somatostatin analogues
#258OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS
#259N-PYRAZOLE-2-PYRIDINE CARBOXAMIDE DERIVATIVE
#260Electrical stimulation of iliohypogastric nerve to alleviate chronic pelvic pain
#261DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE
#262SUSTAINED RELEASE OF MICROCRYSTALLINE PEPTIDE SUSPENSIONS
#263Peptide slow-release formulations
#264METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#265USE OF SOMATOSTATIN ANALOGS IN MYOCARDIAL PERFUSION IMAGING
#266Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles
#267USE OF SOMATOSTATIN OR ONE OF ITS ANALOGUES FOR PREPARING A MEDICAMENT INTENDED TO REGULATE THE OVARIAN FOLLICULAR RESERVE IN NON-MENOPAUSAL WOMEN
#268OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS
#269Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof
#270Novel Composition for Tumor Growth Control
#271MICROSPHERES FOR THE SUSTAINED RELEASE OF OCTREOTIDE WITH A LOW INITIAL BURST
#272MICROSPHERES FOR RELEASING AN OCTREOTIDE COMPOUND WITHOUT AN INITIAL TIME LAG
#273THERAPY PROCEDURE FOR DRUG DELIVERY FOR TRIGEMINAL PAIN
#274USE OF SOMATOSTATIN ANALOGS IN CLUSTER HEADACHE
#275Non-polymeric compositions for controlled drug delivery
#276Octreotide implant having a release agent and uses thereof
#277STABILIZING ALKYLGLYCOSIDE COMPOSITIONS AND METHODS THEREOF
#278Controlled release copolymer formulation with improved release kinetics
#279Somatostatin analogs and IGF-I inhibition for breast cancer prevention
#280Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof
#281Therapy procedure for drug delivery for trigeminal pain
#282Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
#283Methods for treatment of headaches by administration of oxytocin
#284Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
#285Process of preparing microspheres for sustained release having improved dispersibility and syringeability
#286Modulation of Peripheral Clocks in Adipose Tissue
#287Composition for Sustained Release Delivery of Proteins or Peptides
#288COMBINATION OF SOMATOSTATIN-ANALOGS WITH DOPAMINE- OR GROWTH HORMONE RECEPTOR ANTAGONIST
#289Methods for treatment of headaches by administration of oxytocin
#290Treating liver diseases
#291BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING SUMATRIPTAN
#292Pharmaceutical composition comprising cyclic somatostatin analogues
#293SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
#294Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma
#295Sustained Delivery Formulations of Octreotide Compounds
#296GLP-1 AND METHODS FOR TREATING DIABETES
#297Treatment of Insulin Resistance/Metabolic Syndrome to Alleviate the Risks of Dementia
#298Controlled release formulations of octreotide
#299Somatostatin analogue formulations
#300Delivery of dry formulations of octreotide